Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yadav, Dhananjay"'
Autor:
Eslami Jamshid, M. Suryavanshi Dayanand, K. Mohapatra Ranjan, N.E. Kassem Mohamed, Nair P. Radhakrishnan, J. Gómez-Busto Federico, R.M.C. Santos Maria, C. Sczancoski Júlio, K. Sugunan Sunish, Ravalli Silvia, T. Masallat Doaa, Yadav Dhananjay, T. Gaikwad Suresh, D’Agata Velia, Sasi Soorya, K. Mohapatra Pranab, Musumeci Giuseppe, L. Espinoza-Ramírez Ana, S. Cavalcante Laecio, Betul Cakir Fatma, Kebudi Rejin, C. Nogueira Içamira, Lauretta Giovanni, Hatami Neda, Di Rosa Michelino, M. El-Ajaily Marei, C.V. Neto Bartolomeu, Maugeri Grazia, Akbarzadeh Marzieh, Mathew Suresh, I. Ortiz Mario, Páramo-Cano Tatjana, S. Rajbhoj Anjali, B. de Sousa Priscila, Amiri Aazadeh, Silbermann Michael, R. Barik Soumya, Longo Elson, K. Manjul Rajesh, B. Gade Vilas, Mahal Ahmed, N. Gaikwad Dhananjay, Singh Chauhan Pallavi
Publikováno v:
Micro and Nanosystems. 14:92-100
Nanotechnology has gained momentum in recent years in the field of drug delivery, including nanomedicine and nano-delivery systems. Several applications such as biological agents, chemotherapeutic agents and immunotherapeutic agents are used for the
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 21:210-216
The coronavirus, also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus-19), with its rapid rate of transmission, has progressed with a great impact on respiratory function and mortality worldwide. The nasal cavity is the promising
Autor:
Jin Jun-O, Priyanka Bhimaneni Sai, Viola Miranda Adriana, Singh Kavita, Kumar Anoop, Matiashova Lolita, Dhar Amrit, B.R Shrinidhi, S. Chauhan Pallavi, Jain Singhai Nidhi, Papakosta Vasiliki, Yadav Smriti, Mishra Meerambika, Zacharopoulou Lefkothea, Yadav Dhananjay, Ramteke Suman, Barreca Davide, V. Pujar Gurubasavaraj, Danilchenko Valeriia, Ganesh Neenu, Tsagkaris Christos, H.J Pooja, Kumar Inturi Bharath
Publikováno v:
Anti-Infective Agents. 18:326-331
Japanese encephalitis virus (JEV) is an arthropod-borne flavivirus that belongs to the Flaviviridae family affecting millions of people worldwide. There is no specific drug approved for the treatment of this infection and also available vaccines are
Autor:
Siraj Bushra, S. Chauhan Pallavi, Jin Jun-O, Kumar Inturi Bharath, Prakash Singh Prem, Ganesh Neenu, Kumar Dubey Sunil, Singh Kavita, Priyanka Bhimaneni Sai, Maria Faisca Phillips Ana, Wadood Abdul, Maniscalco Mauro, B.R Shrinidhi, V. Pujar Gurubasavaraj, Kumar Anoop, Sikander Azam Syed, Yadav Smriti, H. Al-Mazroea Abdulhadi, H.J Pooja, Mishra Meerambika, Gorantla Srividya, Rafi Sidra, Justin Carlus S., Singhvi Gautam, Uddin Reaz, M. Abdallah Atiyeh, M. Al-Harbi Khalid, Krishna Rapalli Vamshi, Hannah Carlus Fiona, Waghule Tejashree, Yadav Dhananjay, Khalid Al-Harbi Mazen, Narayan Saha Ranendra
Publikováno v:
Letters in Drug Design & Discovery. 17:1027-1035
Background: Aminoglycoside 6'-N-acetyltransferase type Ib (AAC(6')-Ib) from Klebsiella pneumoniae is an established drug target and has conferred insensitivity to aminoglycosides. Aminoglycosides are often inactivated by aminoglycoside modifying enzy